Benzinga's Volume Movers
Heron Therapeutics Inc (NASDAQ: HRTX) shares climbed 19.37 percent to $40.06. The volume of Heron Therapeutics shares traded was 1652 percent higher than normal. Heron Therapeutics reported positive top-line results from Phase 2 study of HTX-011.
Intra-Cellular Therapies Inc (NASDAQ: ITCI) surged 5.21 percent to $47.29. The volume of Intra-Cellular Therapies shares traded 755 percent higher than normal. Intra-Cellular Therapies priced 6,900,000 shares of common stock at $43.50 per share.
First Niagara Financial Group Inc. (NASDAQ: FNFG) shares moved up 14.99 percent to $10.30. The volume of First Niagara Financial traded was 557 percent higher than normal. Bloomberg reported that First Niagara Financial is exploring a possible sale of the firm, according to sources.
Biomed Realty Trust Inc (NYSE: BMR) shares rose 11.73 percent to $21.43. The volume of Biomed Realty Trust shares traded was 398 percent higher than normal. According to Bloomberg, BioMed Realty had engaged the services of Morgan Stanley for advice on a potential takeout. Canaccord Genuity upgraded BioMed Realty Trust from Hold to Buy and raised the price target from $21.00 to $23.00.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.